ArticleCardiology research and practice2022

Sildenafil for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: A Phase I/II Randomized Clinical Trial, SILDAT-TAHA6 Trial.

Armin Attar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.